A four-gene signature-derived risk score for glioblastoma:prospects for prognostic and response predictive analyses

【Author】

Mianfu Cao;Juan Cai;Ye Yuan;Yu Shi;Hong Wu;Qing Liu;Yueliang Yao;Lu Chen;Weiqi Dang;Xiang Zhang;Jingfang Xiao;Kaidi Yang;Zhicheng He;Xiaohong Yao;Yonghong Cui;Xia Zhang;Xiuwu Bian;Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China;Department of Kidney, Southwest Hospital, Third Military Medical University (Army Medical University);

【Institution】

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Key Laboratory of Tumor Immunopathology, Ministry of Education of China;Department of Kidney, Southwest Hospital, Third Military Medical University (Army Medical University);

【Abstract】

Objective: Glioblastoma(GBM) is the most common primary malignant brain tumor regulated by numerous genes, with poor survival outcomes and unsatisfactory response to therapy.Therefore, a robust, multi-gene signature-derived model is required to predict the prognosis and treatment response in GBM.Methods: Gene expression data of GBM from TCGA and GEO datasets were used to identify differentially expressed genes(DEGs)through DESeq2 or LIMMA methods.The DEGs were then overlapped and used for survival analysis by univariate and multivariate COX regression.Based on the gene signature of multiple survival-associated DEGs, a risk score model was established,and its prognostic and predictive role was estimated through Kaplan–Meier analysis and log-rank test.Gene set enrichment analysis(GSEA) was conducted to explore high-risk score-associated pathways.Western blot was used for protein detection.Results: Four survival-associated DEGs of GBM were identified: OSMR, HOXC10, SCARA3, and SLC39A10.The four-gene signature-derived risk score was higher in GBM than in normal brain tissues.GBM patients with a high-risk score had poor survival outcomes.The high-risk group treated with temozolomide chemotherapy or radiotherapy survived for a shorter duration than the low-risk group.GSEA showed that the high-risk score was enriched with pathways such as vasculature development and cell adhesion.Western blot confirmed that the proteins of these four genes were differentially expressed in GBM cells.Conclusions: The four-gene signature-derived risk score functions well in predicting the prognosis and treatment response in GBM and will be useful for guiding therapeutic strategies for GBM patients.

【Keywords】

Differentially expressed genes;;gene set enrichment analysis;;glioblastoma prognosis;;radiotherapy;;temozolomide chemotherapy

References

To explore the background and basis of the node document

Springer Journals Database

Total: 10 articles

  • [1] Yuan-Yuan Xu;Pei Gao;Ying Sun;You-Rong Duan;State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University;, Development of targeted therapies in treatment of glioblastoma, Cancer Biology & Medicine,
  • [2] Sumadi Lukman Anwar;Wahyu Wulaningsih;Johnathan Watkins;PILAR Research Network;Division of Surgical Oncology,Department of Surgery,Faculty of Medicine Universitas Gadjah Mada;Division of Hemato-Oncology,Department of Internal Medicine,Faculty of Medicine Universitas Gadjah Mada;MRC Unit for Lifelong Health and Ageing,University College London;Institute of Molecular and Mathematical Biomedicine,King's College London;, Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs, Cancer Biology & Medicine,
  • [3] Charles O. Brown;;Jeanine Schibler;;Matthew P. Fitzgerald;;Neeraj Singh;;Kelley Salem;;Fenghuang Zhan;;Apollina Goel, Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma, Leukemia Research,
  • [4] Jinkuk Kim;;In-Hee Lee;;Hee Jin Cho;;Chul-Kee Park;;Yang-Soon Jung;;Yanghee Kim;;So Hee Nam;;Byung Sup Kim;;Mark D. Johnson;;Doo-Sik Kong;;Ho Jun Seol;;Jung-Il Lee;;Kyeung Min Joo;;Yeup Yoon;;Woong-Yang Park;;Jeongwu Lee;;Peter J. Park;;Do-Hyun Nam, Spatiotemporal Evolution of the Primary Glioblastoma Genome, Cancer Cell,

More>>

Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 4 articles

  • [1] Detecting robust gene signature through integrated analysis of multiple types of high-throughput data in liver cancer, Acta Pharmacologica Sinica, 2007 (12)
  • [2] Interaction of cellular-localized signature modules in response to prostate cancer, Progress in Natural Science, 2007 (11)
  • [3] Tohru Utsunomiya;Masahiro Okamoto;Shigeki Wakiyama;Masaji Hashimoto;Kengo Fukuzawa;Takahiro Ezaki;Shinichi Aishima;Yasuji Yoshikawa;Taizo Hanai;Hiroshi Inoue;Graham F Barnard;Masaki Mori;, A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease, World Journal of Gastroenterology, 2007 (03)
  • [4] Yan Wang;Reda Rawi;Daniel Hoffmann;Binlian Sun;Rongge Yang;, Inference of Global HIV-1 Sequence Patterns and Preliminary FeatureAnalysis, Virologica Sinica, 2013 (04)